Trebananib
Showing 1 - 25 of 29
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +15 more
- trebananib
- +3 more
-
Buffalo, New York
- +1 more
Sep 8, 2022
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
Advanced Renal Cell Carcinoma Trial (Sunitinib, Trebananib)
Prostatic Tumors, Prostate Cancer, Tumor, Prostate Trial in Bethesda, Philadelphia (AMG 386, Abiraterone, Prednisone)
Completed
- Prostatic Neoplasms
- +3 more
- AMG 386
- +2 more
-
Bethesda, Maryland
- +1 more
Feb 11, 2019
Cancer Target Therapy Efficacy
Active, not recruiting
- Cancer
- RNA sequencing
- +5 more
-
Walnut, California
- +6 more
Sep 13, 2021
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial (AMG 386, Paclitaxel, AMG 386 Placebo)
Completed
- Ovarian Cancer
- +2 more
- AMG 386
- +2 more
- (no location specified)
Dec 16, 2019
Breast Cancer, Breast Tumors, Breast Tumors Trial in Belgium, France, United States (AMG 386 30 mg/kg, Paclitaxel and
Completed
- Breast Cancer
- +9 more
- AMG 386 30 mg/kg, Paclitaxel and Trastuzumab
- +3 more
-
Tucson, Arizona
- +22 more
Apr 2, 2019
Glioblastoma Multiforme Trial in United States (Amgen 386, Bevacizumab)
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer Trial in Worldwide (AMG386 plus PLD, Placebo plus PLD)
Terminated
- Fallopian Tube Cancer
- +2 more
- AMG386 plus PLD
- Placebo plus PLD
-
Los Angeles, California
- +105 more
Nov 27, 2017
CNS Tumor, Solid Tumor Trial in Canada, United States (procedure, other, biological)
Completed
- Central Nervous System Neoplasm
- Solid Neoplasm
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Birmingham, Alabama
- +21 more
Sep 30, 2016
Advanced Solid Tumors, Kidney Disease, Renal Impairment Trial in United States (AMG 386 + Paclitaxel, AMG 386)
Completed
- Advanced Solid Tumors
- +2 more
- AMG 386 + Paclitaxel
- AMG 386
-
Atlanta, Georgia
- +3 more
Nov 1, 2017
Tumors, Advanced Solid Trial (Trebananib 3 mg/kg, Trebananib 10 mg/kg, Trebananib 30 mg/kg)
Completed
- Neoplasms, Advanced Solid
- Trebananib 3 mg/kg
- +2 more
- (no location specified)
Aug 19, 2015
Adult Solid Tumor, Lung Carcinoid Tumor, Recurrent Digestive System Neuroendocrine Tumor G1 Trial in Vancouver, Hamilton,
Completed
- Adult Solid Neoplasm
- +10 more
- Laboratory Biomarker Analysis
- +3 more
-
Vancouver, British Columbia, Canada
- +2 more
Oct 5, 2015
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer Trial in Worldwide (AMG 386, AMG 386 Placebo, Paclitaxel)
Completed
- Fallopian Tube Cancer
- +2 more
- AMG 386
- +2 more
-
Phoenix, Arizona
- +224 more
Dec 14, 2016
Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer Trial in Worldwide (AMG 386, Paclitaxel, AMG 386 Placebo)
Terminated
- Fallopian Tube Cancer
- +2 more
- AMG 386
- +3 more
-
Birmingham, Alabama
- +309 more
Feb 22, 2017
Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States (Laboratory
Completed
- Adult Angiosarcoma
- +3 more
- Laboratory Biomarker Analysis
- Trebananib
-
Lewes, Delaware
- +69 more
Sep 28, 2015
Non Small Cell Lung Cancer Trial in Worldwide (AMG 386, AMG 386 Placebo, Pemetrexed)
Completed
- Non Small Cell Lung Cancer
- AMG 386
- +3 more
-
Fayetteville, Arkansas
- +34 more
May 18, 2016
Advanced Renal Cell Carcinoma Trial (AMG 386, Sorafenib, AMG 386 IV)
Completed
- Advanced Renal Cell Carcinoma
- AMG 386
- +2 more
- (no location specified)
Feb 23, 2016
Advanced Hepatocellular Carcinoma, Inoperable Hepatocellular Carcinoma Trial (AMG 386, Sorafenib)
Completed
- Advanced Hepatocellular Carcinoma
- Inoperable Hepatocellular Carcinoma
- AMG 386
- Sorafenib
- (no location specified)
Mar 7, 2016
Carcinoma, Fallopian Tube Cancer, Ovarian Cancer Trial in Australia, Belgium, Spain (AMG 386, paclitaxel and carboplatin)
Completed
- Carcinoma
- +3 more
- AMG 386, paclitaxel and carboplatin
-
Footscray, Victoria, Australia
- +7 more
Oct 13, 2015
Cancer, Carcinoma, Colon Cancer Trial (AMG 386, AMG 386 Placebo, FOLFIRI)
Completed
- Cancer
- +9 more
- AMG 386
- +2 more
- (no location specified)
Aug 14, 2015
Cancer, Carcinoma, Fallopian Tube Cancer Trial in Australia, Belgium, United States (A1: AMG 386 10 mg/kg + Liposomal
Completed
- Cancer
- +8 more
- A1: AMG 386 10 mg/kg + Liposomal doxorubicin
- +3 more
-
Tucson, Arizona
- +15 more
Sep 25, 2015
Locally Recurrent and Metastatic Breast Cancer Trial in Worldwide (AMG 386 Placebo, AMG 386, Bevacizumab)
Completed
- Locally Recurrent and Metastatic Breast Cancer
- AMG 386 Placebo
- +3 more
-
Litchfield Park, Arizona
- +76 more
Oct 7, 2015